Back
ESC Premium Access

Early initiation of dual anti-platelet therapy following an acute coronary syndrome: the clinical reality.

logo

Session: Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice (EBAC Accredited)
Topic: Thrombosis and platelets
Speaker: Professor S. James (Uppsala, SE)
Sponsored by AstraZeneca
Event: ESC Congress 2017

Congress Presentation

1

About the speaker

Professor Stefan James

Uppsala University, Uppsala (Sweden)
38 presentations
2 followers

4 more presentations in this session

Welcome and introduction - Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice.

Speaker: Professor P. Steg (Paris, FR)

Access
Slides
Video
1
Thumbnail

Extending the duration of dual antiplatelet therapy - Who could benefit?

Speaker: Professor D. Angiolillo (Jacksonville, US)

Access
Slides
Video
0
Thumbnail

Discussion - Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice.

Speaker: Professor P. Steg (Paris, FR) Professor D. Angiolillo (Jacksonville, US) Professor S. James (Uppsala, SE) Professor R. Mehran (New York, US)

Access
Video
0
Thumbnail

Summary and Close - Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice.

Speaker: Professor R. Mehran (New York, US)

Access
Slides
Video
0
Thumbnail

Access the full session

Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice (EBAC Accredited)

Speakers: Professor S. James, Professor P. Steg, Professor D. Angiolillo, Professor P. Steg, Professor D. Angiolillo...
Access
0
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk